article · Naunyn-Schmiedeberg s Archives of Pharmacology

PFDN1 silencing disrupts critical cancer pathways in triple-negative breast cancer: investigating migration, cell cycle, and apoptosis as a new target therapy

20253 citationsAlexandria University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

RNA modifications and cancer
Cancer-related Molecular Pathways
Ubiquitin and proteasome pathways

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1007/s00210-025-03975-6

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.